SpyGlass in Post Liver Transplant Biliary Complications.
Prospective Evaluation of SpyGlass Direct Visualization System in Post Liver Transplant Biliary Stricture.
2 other identifiers
interventional
20
1 country
1
Brief Summary
The purpose of this study is to describe SpyGlass choledochoscopy in patients with post orthotopic liver transplant (OLT) biliary strictures prior to endoscopic therapy and ductal changes after treatment stents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2015
CompletedFirst Posted
Study publicly available on registry
September 7, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedApril 17, 2019
April 1, 2019
1.3 years
September 2, 2015
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Documentation of biliary ductal changes in post-liver transplant biliary complications.
The study aim is to describe biliary ductal changes in post-liver transplant presenting biliary complications
2 years
Secondary Outcomes (1)
Number of Participants with Adverse Events.
2 years
Other Outcomes (1)
Procedural success rate:
1 year
Study Arms (1)
SpyGlass Choledochoscopy procedure
EXPERIMENTALAny patient referred to endoscopic management for biliary post liver transplant complication without previous treatment will be submitted to SpyGlass (direct visualization system) choledochoscopy procedure.
Interventions
SpyGlass (direct visualization system) choledochoscopy procedure will be performed pre and post biliary complication treatment
Eligibility Criteria
You may qualify if:
- Patients referred to endoscopic management for biliary post liver transplant complication without previous treatment
You may not qualify if:
- Patients referred to endoscopic management for biliary post liver transplant complication with any previous treatment.
- Below 18 years of age
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Israelita Albert Einstein
São Paulo, São Paulo, Brazil
Related Publications (4)
Chen YK, Pleskow DK. SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). Gastrointest Endosc. 2007 May;65(6):832-41. doi: 10.1016/j.gie.2007.01.025.
PMID: 17466202BACKGROUNDDraganov PV, Lin T, Chauhan S, Wagh MS, Hou W, Forsmark CE. Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc. 2011 May;73(5):971-9. doi: 10.1016/j.gie.2011.01.003. Epub 2011 Mar 17.
PMID: 21419408BACKGROUNDTringali A, Lemmers A, Meves V, Terheggen G, Pohl J, Manfredi G, Hafner M, Costamagna G, Deviere J, Neuhaus H, Caillol F, Giovannini M, Hassan C, Dumonceau JM. Intraductal biliopancreatic imaging: European Society of Gastrointestinal Endoscopy (ESGE) technology review. Endoscopy. 2015 Aug;47(8):739-53. doi: 10.1055/s-0034-1392584. Epub 2015 Jul 6.
PMID: 26147492BACKGROUNDHasan M, Canipe A, Tharian B, Navaneethan U, Varadarajulu S, Hawes R. Digital cholangioscopy-directed removal of a surgical staple from a strictured bile duct. Gastrointest Endosc. 2015 Nov;82(5):958. doi: 10.1016/j.gie.2015.05.035. Epub 2015 Jun 25. No abstract available.
PMID: 26117180BACKGROUND
Study Officials
- STUDY DIRECTOR
ANGELO P FERRARI, MD
Attending physician
- PRINCIPAL INVESTIGATOR
FERNANDA P MARTINS, MD
Attending physician
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
September 2, 2015
First Posted
September 7, 2015
Study Start
March 1, 2016
Primary Completion
June 1, 2017
Study Completion
October 1, 2018
Last Updated
April 17, 2019
Record last verified: 2019-04